Breaking News, Promotions & Moves

GeneDx Appoints Lisa Gurry as Chief Business Officer

Truveta co‑founder and longtime Microsoft leader will advance data and information services for long-term growth.

By: Rachel Klemovitch

Assistant Editor

GeneDx appointed Lisa Gurry as Chief Business Officer (CBO), effective immediately. In this newly-created role, Gurry will lead GeneDx’s next phase of transformation, advancing data and information services across biopharma, health systems, and other partners to accelerate the long-term vision of enabling precision medicine. As Chief Business Officer, Gurry will architect and operate GeneDx’s strategic business operations and partnership models that open doors and create opportunities to unlo...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters